NCT02736175View on ClinicalTrials.gov

OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

438

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

July 31, 2016

Conditions
Post-Surgical Ocular PainPost-Surgical Ocular Inflammation
Interventions
DRUG

Dexamethasone

OTHER

Placebo Vehicle

Sponsors
All Listed Sponsors
lead

Ocular Therapeutix, Inc.

INDUSTRY

NCT02736175 - OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery | Biotech Hunter | Biotech Hunter